I Read The News Today Oh Boy! 25-Feb-2019

Monday, Feb 25 2019 by
12

Morning all!

Quartix Holdings ( Quartix Holdings (LON:QTX) ) – 243p – £116m – PER 21

Final Results For The 12 Months To End December 2018 – Revenue up 5%, PBT up 22%, Diluted EPS up 16% (14.19p), Net Cash down by about 10% and, strangely, the Dividend is down about the same amount.

I still don’t see value here or the reason for such a high rating – I still feel I am perhaps missing something, hopefully not!

Tristel ( Tristel (LON:TSTL) ) – 302p – £134m – PER 26.6

Interim Results For The 6 Months To End December 2018 – Revenue up 12%, PBT up 20%, Interim Dividend up 28%, Net Cash level down slightly. Sales growth has been in the middle of the target range in H1, no real view on H2 or FY.

I still don't see how this is so highly rated. 

As always, all comment most welcome!

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way

Disclaimer:  

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.


Do you like this Post?
Yes
No
12 thumbs up
0 thumbs down
Share this post with friends



Quartix Holdings plc is a United Kingdom-based supplier of vehicle tracking systems and services. The Company operates in designing, development and marketing of vehicle tracking devices and the provision of related data services segment. The Company offers subscription-based vehicle tracking systems, software and services in the United Kingdom. Its vehicle tracking systems incorporate instrumentation to identify and transmit location, speed and acceleration data to the Company on a real-time basis. Its vehicle tracking software system provides business critical reporting, and analysis of vehicle and driver data, including timesheets and other customer Key Performance Indicator (KPIs) to customers via any Internet-enabled device. The Company has an overseas branch in France and an overseas subsidiary in the United States. The Company's subsidiaries include Quartix Limited and Quartix Inc, which are engaged in the business of vehicle tracking. more »

LSE Price
258p
Change
 
Mkt Cap (£m)
123.7
P/E (fwd)
22.2
Yield (fwd)
4.3

Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company's technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals. The segments products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The segments products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The segments products are marketed under the brand, Crystel. Its manufacturing facility is located in Newmarket, Cambridgeshire. more »

LSE Price
310p
Change
-0.8%
Mkt Cap (£m)
139.1
P/E (fwd)
26.8
Yield (fwd)
1.9



  Is LON:QTX fundamentally strong or weak? Find out More »


5 Posts on this Thread show/hide all

MrContrarian 25th Feb 1 of 5
4

My morning smallcap tweet: FAB not fab, no clap for TAP.

Fusion Antibodies (LON:FAB), Taptica International (LON:TAP), Tristel (LON:TSTL)

Fusion Antibodies (FAB) warns FY rev expected to be materially below current market expectations but at least £2.1m.
Taptica (TAP) current trading 'varied', performance-based advertising continuing to be weak. Tremor robust. I hold.
Tristel (TSTL) H1 pretax (before share-based payments) beats Dec guidance of £2.2m by £0.2m. Rev up 12%.

| Link | Share
Asagi 25th Feb 2 of 5

my understanding is that Quartix Holdings (LON:QTX) accounting policies are very conservative, meaning that profit is understated versus other companies. Check valuation against free cash flow. The company trades at around 18 times free cash flow - nearly all the reported EPS is matched by cash. Company also has a strong balance sheet. I'm still of the opinion that it looks expensive but not as expensive as appears on first glance.

Asagi (no position)

| Link | Share
wilkonz 25th Feb 3 of 5

Taptica International (LON:TAP) reports:

The business remains highly cash generative and with a strong balance sheet. As at 31 December 2018, Taptica had net cash of $54.4 million, which was following a $2.7 million dividend paid to shareholders on 20 November 2018.

The Company confirms that it closed 2018 in-line with management expectations and will publish its final results for the year ended 31 December 2018 on 26 March 2019.

This doesn't sound too bad. The share price has fallen to 170 pence from its recent high of 225 on 5th February (down 6.5% today so far). I don't hold any of these shares yet, but if they fell to 134 where they were on 22nd January they would certainly become attractive.

| Link | Share
Nick Ray 25th Feb 4 of 5
2

I think Tristel (LON:TSTL) is highly rated because it is very consistent. About 90% of its quality and momentum metrics are above the median value. In probability terms it might not have the highest returns but it has a very high probability of a good return.

| Link | Share | 1 reply
Gray Woods 3rd Mar 5 of 5
1

In reply to post #451758

I'd imagine it's more to do with the anticipation around American regulatory approval for its disinfectant to be used on medical devices which they've been chasing for years, if they get it the US market is obviously a lot bigger than the UK's and others so potentially a lot of growth potential.

Blog: The Lone Wolf Investor
| Link | Share

Please subscribe to submit a comment






Stock Picking Tutorial Centre



Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis